首页> 美国卫生研究院文献>Blood >Neoplasia: Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPα in p210BCR/ABL-expressing cells
【2h】

Neoplasia: Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPα in p210BCR/ABL-expressing cells

机译:瘤形成:c-Myb和GATA-2的转录抑制与表达p210BCR / ABL的细胞中C /EBPα的生物学作用有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ectopic C/EBPα expression in p210BCR/ABL-expressing hematopoietic cells induces granulocytic differentiation, inhibits proliferation, and suppresses leukemogenesis. To assess the underlying mechanisms, C/EBPα targets were identified by microarray analyses. Upon C/EBPα activation, expression of c-Myb and GATA-2 was repressed in 32D-BCR/ABL, K562, and chronic myelogenous leukemia (CML) blast crisis (BC) primary cells but only c-Myb levels decreased slightly in CD34+ normal progenitors. The role of these 2 genes for the effects of C/EBPα was assessed by perturbing their expression in K562 cells. Ectopic c-Myb expression blocked the proliferation inhibition– and differentiation-inducing effects of C/EBPα, whereas c-Myb siRNA treatment enhanced C/EBPα-mediated proliferation inhibition and induced changes in gene expression indicative of monocytic differentiation. Ectopic GATA-2 expression suppressed the proliferation inhibitory effect of C/EBPα but blocked in part the effect on differentiation; GATA-2 siRNA treatment had no effects on C/EBPα induction of differentiation but inhibited proliferation of K562 cells, alone or upon C/EBPα activation. In summary, the effects of C/EBPα in p210BCR/ABL-expressing cells depend, in part, on transcriptional repression of c-Myb and GATA-2. Since perturbation of c-Myb and GATA-2 expression has nonidentical consequences for proliferation and differentiation of K562 cells, the effects of C/EBPα appear to involve dif-ferent transcription-regulated targets.
机译:在表达p210 BCR / ABL 的造血细胞中异位C /EBPα表达诱导粒细胞分化,抑制增殖,并抑制白血病的发生。为了评估潜在的机制,通过微阵列分析鉴定了C /EBPα靶标。在C /EBPα激活后,c-Myb和GATA-2的表达在32D-BCR / ABL,K562和慢性骨髓性白血病(CML)blast危机(BC)原代细胞中被抑制,但CD34中仅c-Myb含量略有降低 + 正常祖细胞。通过扰动它们在K562细胞中的表达来评估这两个基因对C /EBPα的作用。异位c-Myb表达阻止了C /EBPα的增殖抑制和诱导分化作用,而c-Myb siRNA处理增强了C /EBPα介导的增殖抑制并诱导了指示单核细胞分化的基因表达变化。异位GATA-2表达抑制了C /EBPα的增殖抑制作用,但部分阻断了对分化的影响。 GATA-2 siRNA处理对C /EBPα诱导分化没有影响,但单独或通过C /EBPα活化抑制K562细胞的增殖。总之,C /EBPα在表达p210 BCR / ABL 的细胞中的作用部分取决于c-Myb和GATA-2的转录抑制。由于c-Myb和GATA-2表达的扰动对K562细胞的增殖和分化具有不同的后果,因此C /EBPα的作用似乎涉及不同的转录调控靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号